Halobetasol Propionate is Used for treating corticosteroid-responsive dermatoses, including psoriasis. It was first introduced by Sun Pharmaceutical Industries Inc in its drug Ultravate on Dec 17, 1990. Other drugs containing Halobetasol Propionate are Bryhali, Lexette. 10 different companies have introduced drugs containing Halobetasol Propionate.

Halobetasol Propionate Patents

Given below is the list of patents protecting Halobetasol Propionate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Lexette	US10857159 (Pediatric)	Halobetasol foam composition and method of use thereof	May 30, 2037	Mayne Pharma
Lexette	US10857159	Halobetasol foam composition and method of use thereof	Nov 30, 2036	Mayne Pharma
Lexette	US11020407	Corticosteroid containing foam compositions and method of manufacture thereof	Nov 30, 2036	Mayne Pharma
Ultravate	US8962028	Topical steroid composition and method	Jun 19, 2033	Lacer Pharma
Bryhali	US10478502	Pharmaceutical formulations containing corticosteroids for topical administration	Nov 02, 2031	Bausch
Bryhali	US11839656	Pharmaceutical formulations containing corticosteroids for topical administration	Nov 02, 2031	Bausch
Bryhali	US11957753	Pharmaceutical formulations containing corticosteroids for topical administration	Nov 02, 2031	Bausch
Bryhali	US11986527	Pharmaceutical formulations containing corticosteroids for topical administration	Nov 02, 2031	Bausch
Bryhali	US12076403	Pharmaceutical formulations containing corticosteroids for topical administration	Nov 02, 2031	Bausch
Bryhali	US8809307	Pharmaceutical formulations containing corticosteroids for topical administration	Nov 02, 2031	Bausch
Bryhali	US6517847	Topical gel delivery system	Aug 03, 2020 (Expired)	Bausch

Add above patents to watchlist

Halobetasol Propionate's Family Patents

Full family tree

Halobetasol Propionate Generic API Manufacturers

Several generic applications have been filed for Halobetasol Propionate. The first generic version for Halobetasol Propionate was by Fougera Pharmaceuticals Inc and was approved on Dec 16, 2004. And the latest generic version is by Padagis Israel Pharmaceuticals Ltd and was approved on Aug 11, 2023.

Given below is the list of companies who have filed for Halobetasol Propionate generic, along with the locations of their manufacturing plants worldwide.